Ivermectin and Fenbendazole Success Stories: Flesh Eating Infections, Alzheimer's, Cancer, & Irritable Bowel Syndrome
In this Substack’s ongoing series of repurposed drug cures we have three new important anecdotal experiences to review.
Our second comment perfectly jibes with all of the turbo cancer research that this Substack has been writing about of late:
Inflammatory bowel disease (IBD) is a very difficult condition to treat successfully. It is a chronic inflammatory condition of the digestive tract. It can lead to ulcers and Crohn's disease, which typically involves diarrhea, rectal bleeding, abdominal pain, fatigue and weight loss. IBD also leads to cancer. Doctors are generally unable to cure this disease, and merely manage it with a variety of rather ineffective drugs and dietary changes.
But what if Ivermectin could easily cure IBD? Let us review my above response citing four germane research studies, starting with the first link entitled, Anti-inflammatory Effects of Ivermectin in the Treatment of Acetic Acid-Induced Colitis in Rats: Involvement of GABAB Receptors.
In a controlled experimental study, we enrolled 78 male Wistar rats (13 groups; 6 rats/group). After colitis induction using acetic acid (4%), IVM, baclofen (a standard GABAB agonist) or the combination of both agents was delivered to rats orally (by gavage), with the same dosage continued for 5 days. The control group received the vehicle, and prednisolone (a standard anti-inflammatory agent) was administered in a separate group as the positive control. Colon samples were collected on the sixth day for histopathological evaluations and measurement of myeloperoxidase (MPO) activity, TNF-α levels, and p-NF-ĸB p65, COX-2 and iNOS expression levels.
IVM exerted promising anti-inflammatory effects in treating acetic acid-induced colitis in rats. Its synergistic effect with baclofen also signified the possible involvement of GABAB receptors in this process.
While the colon is not exactly the same as the stomach lining, we may infer that the underlying inflammatory condition of IBD would respond identically.
The second link I posted is entitled, Ivermectin administration is associated with lower gastrointestinal complications and greater ventilator-free days in ventilated patients with COVID-19: A propensity score analysis, and here we have a similar conclusion:
Ivermectin improved gastrointestinal complications and the number of ventilator-free days in severe COVID-19 patients undergoing mechanical ventilation. Prevention of gastrointestinal symptoms by SARS-Cov-2 might be associated with COVID-19 outcome.
What is curious is that we now know that Ralph Baric started with a COVID variant that was exclusively found in the gastrointestinal tract of swine, then Gain of Functioned it to infect human heart and lung tissue. So it is of little surprise then that in a kind of full circle symptom loop, both the C-19 virus and associated slow kill bioweapon “vaccines” could impact the gastrointestinal tracts of humans.
The third link is entitled, Ivermectin has New Application in Inhibiting Colorectal Cancer Cell Growth, and this study ties in the end result of many GI diseases which culminate in cancer diagnoses.
Colorectal cancer (CRC) is the third most common cancer worldwide and still lacks effective therapy. Ivermectin, an antiparasitic drug, has been shown to possess anti-inflammation, anti-virus, and antitumor properties. However, whether ivermectin affects CRC is still unclear. The objective of this study was to evaluate the influence of ivermectin on CRC using CRC cell lines SW480 and SW1116.
Overall, ivermectin suppressed cell proliferation by promoting ROS-mediated mitochondrial apoptosis pathway and inducing S phase arrest in CRC cells, suggesting that ivermectin might be a new potential anticancer drug therapy for human colorectal cancer and other cancers.
And the end result of treating CRC with Ivermectin should not in the least surprise longstanding readers of this Substack:
In conclusion, we have demonstrated that ivermectin may regulate the expression of crucial molecules Caspase-3, Bax, Bcl-2, PARP, and Cleaved-PARP in the apoptosis pathway by increasing ROS production and inhibiting the cell cycle in the S phase to inhibit colorectal cancer cells (Figure 11). Therefore, current results indicate that ivermectin might be a new potential anticancer drug for treating human colorectal cancer and other cancers.
Is it any wonder then that the Medical Industrial Complex along with the Intelligence Industrial Complex went so hard after Ivermectin? Not only would the murderous “pandemic” hospital protocols have been much harder to implement, but the entire cancer treatment industry would have imploded as cancer rates would have plummeted. Instead, the sick irony is that the DEATHVAX™ was pushed, which is now directly responsible for the turbo cancer phenomenon, and the associated surge in cancer treatment expenditures.
They do not want you to cure yourselves.
They want you genetically modified, sickly, and easy to control.
They want you dead.
Do NOT comply.